Compound class:
Synthetic organic
Comment: ACHN-975 is a hydroxamate-based inhibitor of bacterial UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) and first-in-class to advance to clinical evaluation [2].
|
|